Wealth Shield Partners, LLC Gilead Sciences, Inc. Transaction History

Wealth Shield Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $164,960 - $177,974	-2,437 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $46,904 - $51,249	739 Added 43.52%	2,437 $168,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $101,880 - $116,245	1,698 New	1,698 $110,000
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $177,706 - $207,287	-2,739 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $199,508 - $243,223	2,739 New	2,739 $206,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Shield Partners, LLC with notifications on news.